21.02.2023 • NewsIMCDraw material supplyraw materials

IMCD Expands in South Africa with CPS Oil-Tech Buy

IMCD South Africa has agreed to buy CPS Chemical Oil-Tech, a Durban-based distributor that mostly serves the lubricants and fuel markets. The transaction is expected to close in the second quarter of 2023.

Left to right (standing) - John Fitton, Director CPS Chemicals Oil-Tech; Rajeen...
Left to right (standing) - John Fitton, Director CPS Chemicals Oil-Tech; Rajeen Bothma, Director CPS Chemicals Oil-Tech. Left to right (seating) - Raj Singh, Managing Director CPS Chemicals Oil-Tech; Ryan Harrison, Managing Director IMCD South Africa. © IMCD

CPS Oil-Tech has eight employees and generated revenue of roughly €12 million in the fiscal year ending Feb. 28, 2022. The company supplies raw materials to the petroleum, additive, grease manufacturing and other related industries.

“Joining forces with CPS Oil-Tech will enable IMCD South Africa to offer its customers an increased product offering, through the valued strategic principals that CPS Oil-Tech already represents,” said IMCD South Africa’s managing director Ryan Harrison. “Furthermore, the business unit will become stronger due to the increased expertise and technical knowledge of its staff supporting our continuous efforts and ambitions to further expand within the Sub-Saharan Africa region.”

The deal is just the latest in a string of bolt-on acquisitions that IMCD has announced in the past several months, the most recent being India’s Parkash DyeChem and China’s Shanghai Sanrise Industries & Development last November.

Author: Elaine Burridge, Freelance Journalist

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read